These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 4729733

  • 1. Daily serum follicle-stimulating hormone, luteinizing hormone, and plasma testosterone and androstenedione in hirsute women with polycystic sclerotic ovaries: effects of diethylstilbestrol and norethindrone acetats.
    Daane TA, Dignam WJ, Frankland MV, Simmer HH, Parlow AF.
    Am J Obstet Gynecol; 1973 Oct 01; 117(3):392-9. PubMed ID: 4729733
    [Abstract] [Full Text] [Related]

  • 2. Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone.
    Wild RA, Demers LM, Applebaum-Bowden D, Lenker R.
    Contraception; 1991 Aug 01; 44(2):113-24. PubMed ID: 1893706
    [Abstract] [Full Text] [Related]

  • 3. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
    Furuhjelm M, Carlström K.
    Acta Obstet Gynecol Scand; 1977 Aug 01; 56(4):351-61. PubMed ID: 602703
    [Abstract] [Full Text] [Related]

  • 4. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
    Moutos D, Smith S, Zacur H.
    Contraception; 1995 Aug 01; 52(2):105-9. PubMed ID: 8536446
    [Abstract] [Full Text] [Related]

  • 5. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
    Frölich M, Lachinsky N, Moolenaar AJ.
    Acta Endocrinol (Copenh); 1977 Feb 01; 84(2):333-42. PubMed ID: 138326
    [Abstract] [Full Text] [Related]

  • 6. Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.
    Falsetti L, Galbignani E.
    Contraception; 1990 Dec 01; 42(6):611-9. PubMed ID: 2150631
    [Abstract] [Full Text] [Related]

  • 7. Effects of low dose oral contraceptives containing norethindrome and ethinyl estradiol on serum levels of progesterone and pituitary gonadotropins.
    McGuire JL, Bariso CD, Yuliano E, Hume RJ, Pasquale SA.
    Contraception; 1975 Mar 01; 11(3):329-38. PubMed ID: 1116369
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function.
    Scott JZ, Kletzky OA, Brenner PF, Mishell DR.
    Fertil Steril; 1978 Aug 01; 30(2):141-5. PubMed ID: 98356
    [Abstract] [Full Text] [Related]

  • 9. Serum norethindrone (NET) concentrations following intramuscular NET enanthate injection. Effect upon serum LH, FSH, estradiol and progesterone.
    Goebelsmann U, Stanczyk FZ, Brenner PF, Goebelsmann AE, Gentzschein EK, Mishell DR.
    Contraception; 1979 Mar 01; 19(3):283-313. PubMed ID: 572279
    [Abstract] [Full Text] [Related]

  • 10. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR, Kletzky OA, Brenner PF, Roy S, Nicoloff J.
    Am J Obstet Gynecol; 1977 May 01; 128(1):60-74. PubMed ID: 403765
    [Abstract] [Full Text] [Related]

  • 11. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW, de la Peña A, Chenault CB, Cervantes A.
    Am J Obstet Gynecol; 1975 Jul 01; 122(5):625-36. PubMed ID: 1146928
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens.
    Guerin JF, Rollet J.
    Int J Androl; 1988 Jun 01; 11(3):187-99. PubMed ID: 2970439
    [Abstract] [Full Text] [Related]

  • 13. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF, Mishell DR, Stanczyk FZ, Goebelsmann U.
    Am J Obstet Gynecol; 1977 Sep 15; 129(2):133-40. PubMed ID: 900174
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of norethindrone acetate released from a single silastic implant on serum FSH, LH, progesterone and estradiol-17beta of women during first eight months of treatment.
    Rahman SA, Jha P, Laumas V, Jain AK, Dileepkumar, Takkar D, Hingorani V, Laumas KR.
    Contraception; 1977 Nov 15; 16(5):487-97. PubMed ID: 590011
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of oral contraceptive on the pituitary and plasma L.H. levels and on the hypothalamic LH-RH level (author's transl)].
    Sato N, Yanaihara T, Kanazawa M, Okinaga S, Arai K.
    Nihon Naibunpi Gakkai Zasshi; 1976 Aug 20; 52(8):845-50. PubMed ID: 797581
    [Abstract] [Full Text] [Related]

  • 19. Radioimmunoassays of ethinyl-norgestrienone (R-2323) and medroxyprogesterone acetate (MPA) and their clinical applicability.
    Frick J, Bartsch G, Jakse G.
    Urol Res; 1977 Aug 20; 5(2):55-9. PubMed ID: 69351
    [Abstract] [Full Text] [Related]

  • 20. Control of fertility with oral medication.
    Diddle AW, Watts GF, Gardner WH, Williamson PJ.
    West J Surg Obstet Gynecol; 1964 Aug 20; 72():222-9. PubMed ID: 12305556
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.